Latin America continues its staggering economic growth, and its various national healthcare industries are poised to capitalize on a growing middle class and increased access to quality care and medications.
Currently, Latin America accounts for one-third of emerging market pharmaceutical sales and we anticipate future growth throughout the remainder of the decade. There is still tremendous room for healthcare spending, as regional healthcare spend as a percentage of GDP is only 7.7% (a majority of which comes from out-of-pocket spending).
The full report includes detailed market dynamics for Latin American countries of interest, trading and transaction comps, deal profiles, and a collection of future growth drivers within the region.
Click the PDF link below to view this region report in its entirety.